News Daily News Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies Michael O'Riordan September 27, 2016
News Daily News Los Grandes Cambios en la Presión Arterial Sistólica de una Visita Médica a Otra se asocian a un Mayor Riesgo de Mortalidad Michael O'Riordan September 27, 2016
News Daily News Large Swings in Visit-to-Visit Systolic Blood Pressure Linked With Increased Risk of Death Michael O'Riordan September 27, 2016
News Daily News Low-Dose NOACs Top Warfarin in Asian Patients in Everyday Practice, Retrospective Study Suggests Todd Neale September 26, 2016
News Daily News Las Dosis Bajas de Superan a la Warfarina en Pacientes Asiáticos en la Práctica Rutinaria, según un Estudio Retrospectivo Todd Neale September 26, 2016
News Daily News Amid Sparse Data on Infection After ASD Closure, Experts Urge Focus on Dental Health Yael L. Maxwell September 26, 2016
News Opinion Fellow Talk Continuity Clinics: Indispensable to Medicine but Extraneous for Interventional Cardiology Fellows Ankur Kalra September 24, 2016
News Features Grumbling Over Bundling: Cardiologists React Warily to Plans for Lump-Sum Payments for Cardiac Care Caitlin E. Cox September 23, 2016
News Conference News PCR London Valves 2016 Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance Shelley Wood September 22, 2016
News Daily News Potential Genetic Link Between Platelet Activity and Cardiovascular Disease Identified Michael O'Riordan September 22, 2016
News Daily News CAC Screening Stratifies CVD Event Risk in Statin-Eligible Patients: Heinz Nixdorf Recall Study Michael O'Riordan September 22, 2016
News Daily News Screening for AAA in All 65-Year-Old Men Reduces Mortality, Swedish Study Suggests Todd Neale September 21, 2016
News Opinion Fellow Talk Congrats on Your Structural Fellowship! Now Understand the Challenges Ahead Rahul Sharma, MD September 21, 2016
News Daily News A Step in the Wrong Direction: Weight-Loss Efforts Could Be Hampered by Addition of Wearable Device Yael L. Maxwell September 21, 2016
News Daily News Evolocumab Modifies IVUS-Detected Coronary Atherosclerosis: Topline Results From GLAGOV Michael O'Riordan September 20, 2016
News Industry News Amgen Announces Positive Top-Line Results From Phase 3 GLAGOV Imaging Study Of Repatha® (Evolocumab) September 20, 2016
News Opinion Fellow Talk How Should Fellows Learn From Live Cases? An Interview With Simon Redwood, MD Tiffany Patterson, MBBS September 19, 2016